Japanese Drug Store Chain Growell Launches Takeover Bid For Terashima
This article was originally published in PharmAsia News
Japanese drug store chain Growell Holdings launches a takeover bid for Terashima, a Tsukuba-based drug store chain with around 100 stores. Growell plans to acquire 50.18 percent of Terashima's outstanding shares and take the company as a subsidiary after the deal. Terashima President Takao Terashima was approached by Growell and the two sides started negotiations in August. Growell was established by a merger of Welcia Kanto and Takada Yakyoku. Japanese retailer Aeon Group is the largest share holder of both Growell and Terashima. (Click here for more - Japanese language
You may also be interested in...
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.